These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9146728)

  • 21. Increased transforming growth factor-alpha levels in human colon carcinoma cell lines over-expressing protein kinase C.
    Maruvada P; Levine AE
    Int J Cancer; 1999 Jan; 80(1):72-7. PubMed ID: 9935234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of protein kinase C-alpha-regulated cDNAs associated with breast tumor aggressiveness by differential mRNA display.
    Carey I; Noti JD
    Int J Oncol; 1999 May; 14(5):951-6. PubMed ID: 10200347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C-alpha and -beta play antagonistic roles in the differentiation process of THP-1 cells.
    Dieter P; Schwende H
    Cell Signal; 2000 May; 12(5):297-302. PubMed ID: 10822170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
    Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
    Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype.
    Morse-Gaudio M; Connolly JM; Rose DP
    Int J Oncol; 1998 Jun; 12(6):1349-54. PubMed ID: 9592198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase Calpha expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells.
    Cho Y; Talmage DA
    Exp Cell Res; 2001 Sep; 269(1):97-108. PubMed ID: 11525643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.
    Muscella A; Greco S; Elia MG; Storelli C; Marsigliante S
    J Cell Physiol; 2003 Oct; 197(1):61-8. PubMed ID: 12942541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal regulation of PKC: estrogen up-regulates PKCeta expression in estrogen-responsive breast cancer cells.
    Karp G; Maissel A; Livneh E
    Cancer Lett; 2007 Feb; 246(1-2):173-81. PubMed ID: 16580129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoenzyme-specific protein kinase C and c-Jun N-terminal kinase activation by electrically stimulated contraction of neonatal rat ventricular myocytes.
    Strait JB; Samarel AM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1553-66. PubMed ID: 10900180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
    J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells.
    Fima E; Shtutman M; Libros P; Missel A; Shahaf G; Kahana G; Livneh E
    Oncogene; 2001 Oct; 20(46):6794-804. PubMed ID: 11709714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells.
    Scaglione-Sewell B; Abraham C; Bissonnette M; Skarosi SF; Hart J; Davidson NO; Wali RK; Davis BH; Sitrin M; Brasitus TA
    Cancer Res; 1998 Mar; 58(5):1074-81. PubMed ID: 9500474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer.
    Denham DW; Franz MG; Denham W; Zervos EE; Gower WR; Rosemurgy AS; Norman J
    Surgery; 1998 Aug; 124(2):218-23; discussion 223-4. PubMed ID: 9706141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells.
    Soh JW; Lee YS; Weinstein IB
    J Exp Ther Oncol; 2003; 3(3):115-26. PubMed ID: 14641818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway.
    Zhou JN; Ljungdahl S; Shoshan MC; Swedenborg J; Linder S
    Mol Carcinog; 1998 Apr; 21(4):234-43. PubMed ID: 9585253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells.
    Lee SA; Karaszkiewicz JW; Anderson WB
    Cancer Res; 1992 Jul; 52(13):3750-9. PubMed ID: 1617646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone and phorbol esters require specific protein kinase C isoforms to activate mitogen-activated protein kinases in 3T3-F442A cells.
    MacKenzie S; Fleming I; Houslay MD; Anderson NG; Kilgour E
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):159-65. PubMed ID: 9164852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin.
    Yoshida M; Heike Y; Ohno S; Ikekawa T; Wakasugi H
    Int J Cancer; 2003 Jul; 105(5):601-6. PubMed ID: 12740906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical PKC-zeta and PKC-iota mediate opposing effects on MCF-7 Na+/K+ATPase activity.
    Muscella A; Storelli C; Marsigliante S
    J Cell Physiol; 2005 Nov; 205(2):278-85. PubMed ID: 15887250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of protein kinase C alpha expression by antisense RNA in transfected Jurkat cells.
    López-Lago MA; Freire-Moar J; Barja P
    Eur J Immunol; 1999 Feb; 29(2):466-76. PubMed ID: 10064062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.